Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide

NCT06232460 is registered in ClinicalTrials.gov with Rousselot BVBA as lead sponsor.

NCT NCT06232460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide
Lead sponsor
Rousselot BVBA
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2024
Completion date
July 29, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tolerance